Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Phibro Animal Health Corporation (PAHC:NASDAQ), powered by AI.
Phibro Animal Health Corporation is currently trading at $31.87. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Phibro Animal Health Corporation on Alpha Lenz.
Phibro Animal Health Corporation's P/E ratio is 26.7.
“Phibro Animal Health Corporation trades at a P/E of 26.7 (premium valuation) with strong ROE of 17.8%. 3Y revenue CAGR of 11.2% highlights clear growth momentum.”
Ask for details →Phibro Animal Health Corporation is a pharmaceutical company that focuses on the development, manufacturing, and marketing of a wide range of animal health and mineral nutrition solutions. Primarily, the company serves the livestock and poultry sectors by providing medications and vaccines that enhance the health and productivity of animals. Phibro's extensive product portfolio includes antimicrobials, vaccines, mineral premixes, and specialty products developed to support the animal agriculture industry. The company plays a significant role in improving animal welfare as well as animal-derived food safety, thus contributing directly to the agricultural supply chain. Established in 1946 and headquartered in Teaneck, New Jersey, Phibro operates globally, catering to the needs of veterinarians, farmers, and feed producers across diverse markets. Its products are pivotal in addressing challenges such as outbreaks of diseases among livestock, thereby helping to ensure the profitability and sustainability of animal farming operations worldwide.
“Phibro Animal Health Corporation trades at a P/E of 26.7 (premium valuation) with strong ROE of 17.8%. 3Y revenue CAGR of 11.2% highlights clear growth momentum.”
Ask for details →Phibro Animal Health Corporation (ticker: PAHC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,475 employees. Market cap is $1.3B.
The current price is $31.87 with a P/E ratio of 26.74x and P/B of 4.52x.
ROE is 17.80% and operating margin is 8.52%. Annual revenue is $1.3B.